Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Contract

14 Jul 2023 07:00

RNS Number : 9567F
Galliford Try Holdings PLC
14 July 2023
 

GALLIFORD TRY APPOINTED TO £72M REMODELLING OF LANDMARK LONDON OFFICE

Galliford Try, one of the UK's leading construction groups, announces that its Building business has been appointed by St Martin's Property Investments Limited to undertake the £72m remodelling and refurbishment of Adelaide House in central London.

 

The works consist of the remodelling of the nine-storey, Grade II-listed building, adjacent to London Bridge to a Category A office standard, as well as reconfiguration and enhancement works to external areas including the roof and riverside gardens.

 

Bill Hocking, Chief Executive of Galliford Try, commented: "We are delighted to be working with St Martin's on this landmark building with a prestigious location on the banks of the Thames. Our Building team has a proud record of delivering high-quality, sustainable office spaces within the capital."

 

 

Galliford Try

 

Bill Hocking, Chief Executive 01895 855001

Andrew Duxbury, Finance Director

Kevin Corbett, General Counsel & Company Secretary

 

Notes to Editors 

Galliford Try is a trading name of Galliford Try Holdings plc, a leading UK construction group listed on the London Stock Exchange. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure projects with clients in the public, private and regulated sectors across the UK.

For more information on the building please see https://adelaidehouse.london/. CBRE and Savills are the leasing agents.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTZZGMNGFMGFZM
Date   Source Headline
6th Jul 20233:30 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSTransaction in Own Shares
4th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20232:32 pmRNSTotal Voting Rights
21st Jun 20237:00 amRNSTransaction in Own Shares
9th Jun 20237:00 amRNSTransaction in Own Shares
8th Jun 20237:00 amRNSSettlement Agreed and Special Dividend
7th Jun 20237:00 amRNSTransaction in Own Shares
6th Jun 20237:00 amRNSTransaction in Own Shares
1st Jun 202311:00 amRNSConfirmation of Directorate Change
1st Jun 202310:15 amRNSTotal Voting Rights
1st Jun 20237:00 amRNSTransaction in Own Shares
31st May 20237:00 amRNSTransaction in Own Shares
18th May 20233:30 pmRNSHolding(s) in Company
18th May 20237:00 amRNSTransaction in Own Shares
17th May 20233:00 pmRNSAppointment of Non Executive Director
17th May 20237:00 amRNSTransaction in Own Shares
11th May 20237:10 amRNSContract
10th May 20237:00 amRNSTransaction in Own Shares
3rd May 20237:00 amRNSTransaction in Own Shares
2nd May 202311:00 amRNSTotal Voting Rights
2nd May 20237:10 amRNSContract
2nd May 20237:00 amRNSTransaction in Own Shares
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20232:00 pmRNSDirector/PDMR Shareholding
13th Apr 20237:10 amRNSContract
11th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 202310:00 amRNSTotal Voting Rights
31st Mar 20233:00 pmRNSConfirmation of Director Change
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20237:05 amRNSContract
29th Mar 20237:00 amRNSTransaction in Own Shares
27th Mar 20237:00 amRNSTransaction in Own Shares
24th Mar 20239:37 amRNSCorrection: Transaction in Own Shares
24th Mar 20237:00 amRNSContract
23rd Mar 20237:00 amRNSContract
22nd Mar 20237:00 amRNSTransaction in Own Shares
15th Mar 202310:30 amRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSContract
8th Mar 20237:10 amRNSTransaction in Own Shares
8th Mar 20237:00 amRNSHalf-year Report
7th Mar 20237:00 amRNSTransaction in Own Shares
6th Mar 20237:00 amRNSContract
1st Mar 20239:35 amRNSTotal Voting Rights
27th Feb 20234:00 pmRNSHolding(s) in Company
24th Feb 202310:42 amRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.